chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Less than 1 minute after administration, patient described a metallic taste in the back of her throat.  I asked patient if she felt tightness in her throat and she stated she did not.  I checked her injection site and there was a slight redness at the site, but no more than any other injection site on any of my other patients.  I asked her to remain in the building so I could monitor her.  After 5 minutes or so, the patient stated that she felt as if she had a tightness in her throat as if she had a sore throat from a cold but without the pain.  I again asked if she was having any difficulty swallowing or breathing and she stated she did not, but stated it was just "uncomfortable".  I again asked her to stay close.  The patient stayed with me for another 20 minutes as we discussed topics unrelated to medicine, and she displayed no further symptoms. I again checked the site of administration and there was still only a mild redness at site of injection and no further spreading.  The patient stated she felt much better and i released her to go home with her husband.
Typical and expected side effects were fatigue for ~24 hours and soreness at the site of injection for ~48 hours.  In addition, the morning after the injection I woke up with a bright red face rash and draining on the left nostril, the left eye crusted shut with yellowish drainage, a red blister-like spot on the left lower eyelid, bloodshot eye, and swelling from the eyelid and down into the cheek. The swelling got worse after a couple of days, leading to medical treatment with eye drops and an antibiotic.
PT HAD RECEIVED TDAP ON 4/20/2010 AS A NEW EMPLOYEE.  WHEN ASKED IN THE ER WHEN HER LAST TETANUS SHOT WAS SHE STATED "I HAVE NO IDEA".  WE WERE INSTRUCTED TO REPORT THIS AS AN ADVERSE EVENT.
suspected vaccination failure; I got shingles from the shot too; horrible pain; This case was reported by a consumer and described the occurrence of suspected vaccination failure in a adult patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   Co-suspect products included Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingles vaccine and the 2nd dose of Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine and Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant), shingles and pain. On an unknown date, the outcome of the vaccination failure was unknown and the outcome of the shingles and pain were recovered/resolved.   It was unknown if the reporter considered the vaccination failure, shingles and pain to be related to Shingles vaccine and Shingles vaccine.  Additional details were provided as follows: The age at vaccination was not reported. The age group was not reported but was captured as an adult as per the vaccine indication. After receiving Shingles vaccine, the patient experienced shingles. The patient also had horrible pain for 6 weeks. This case was considered as suspected vaccination failure, since the details regarding the completion of the primary immunization, time to onset for event and laboratory confirmation were not provided.; Sender's Comments:  US-GLAXOSMITHKLINE-US2021AMR073599:same reporter
Patient complained of redness, swelling, intense tenderness to touch at injections site, also redness, tenderness and rash on the inside of arm (opposite of the injection site), also fever of 99.2F, and aches.
Initially my arm was sore, as in getting a flu shot. That faded away, but then on the 11th day I noticed my arm was itchy and tender to the touch and there was a pink oval on my arm at the injection site. The oval is still there today. It measures 5 inches by 3.5 inches. It is still somewhat itchy, but it never swelled. I am not bothered much by this but I thought I should report it.
Addison disease, extreme neck and leg pain, activated dormant Lyme, blurred vision, fatigue, trouble walking, muscle twitching, tingling and numbness in limbs, foot pain, brain fog, memory and word retrieval issues. I spent almost a year in bed and thousand of dollars on treatment, testing and prescriptions.
From an initial report received on 12/13/2000, it was reported that the pt experienced "localized sweling/pain/erythema 24 hours after injection. This progressed to a large abscess requiring incision and drainage." The pt reportedly recovered from this experience.
INJECTION SITE RASH; INJECTION SITE ITCHING; This spontaneous report received from a health care professional concerned a 32 year old female. The patient's weight, height, and medical history were not reported.The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, intramuscular, batch number: Unknown) dose was not reported, administered on 03-APR-2021 on left arm for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported. On APR-2021, the subject experienced injection site rash. On APR-2021, the subject experienced injection site itching. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from injection site rash, and injection site itching. This report was non-serious.
sudden onset of stomachache, nausea and vomiting and multiple (10 plus) seizures
Rt arm with mild redness at injection site, swollen and warm to touch.  Induration 12cm x 14cm with prominent itching.
No adverse effects; patient was  vaccinated with improperly stored PNEUMOVAX 23; This spontaneous report was received from a registered nurse referring to a patient of unknown age and gender. The patient's historical condition, concomitant medications and drug reactions or allergies were not reported.   On 12-APR-2019 , the patient was vaccinated with an improperly stored dose of  pneumococcal vaccine, polyvalent (23-valent)(PNEUMOVAX23) lot #R018136 and expiration date 10-JUL-2020 for prophylaxis (dosage schedule, route, and anatomical location were not reported). The administered dose of the vaccine experienced a temperature excursion below2 degrees Celsius (1.18 C) for 23 hours and 30 minutes, as recorded by a data logger.There was no previous temperature excursion. No adverse effects reported.  This is one of several reports received from the same reporter.; Sender's Comments:  US-009507513-1905USA001733:
Red splotchy rash appeared on face, neck, and shoulders.  She had cried before and during immunization injections.  Rash appeared approximately 3-5 minutes after administration of vaccines.  No respiratory distress, she stated she had no problem breathing.  She was monitored for 30 minutes at the office.  After 15 minutes rash on face had disappeared and only light reddish on neck and shoulders.  Released after 30 minutes with only one red spot below left ear approximately 1 1/2 circular inch.
back pain; bilateral leg pain; This is a spontaneous report from a contactable other health professional (patient). A 50-year-old female patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; lot number: 123302), via an unspecified route of administration on 20Jan2021 at a single dose on the left arm for COVID-19 immunization. The patient's medical history was not reported. Concomitant medications included ergocalciferol (VIT D) and an unspecified vaccine (lot number: P 100242861) taken for an unspecified indication on 01Dec2020. The patient previously took the first dose of BNT162B2 (lot number: EL0140), at 50-years of age via intramuscular route, on 30Dec2020 at 03:30 pm on the left arm for COVID-19 immunization and four days after the injection, patient had severe low back pain, difficulty walking, standing, sitting. The patient was not diagnosed with COVID-19 prior to vaccination. On an unspecified date, the patient experienced back pain along with bilateral leg pain. The patient did not receive any treatment for the reported events. The patient underwent lab test which included nasal swab test which showed negative result on 21Jan2021. The outcome of the events was recovering. The patient was not pregnant at the time of vaccination.
Client developed a mild covid infection 12/8/21 and recovered. He was admitted 12/25 with hypogycemia and mild weakness and sent home He was given his first dose of the Moderna vaccine 1/4/21 at approximately 9AM covid vaccine clinic He developed weakness the next day  (1/5) prompting admission to a hospital and then transition to subacute rehabilitation briefly  Work up at hospital revealed progressive respiratory failure and pneumonia requiring intubation and progressive ascending weakness and sensory loss without upper motor neuron changes.  MRI : nerve root enhancement LP : protein 40, +/- 80 lymphocytes, cultures negative B 12 and B6 normal extensive CSF testing still pending campylobacter and Musk antibodies negative Neurology diagnosed likely AIDP (Guillain-Barre) and an EMG is planned for the near future.  Neurology felt the cause of his GBS was likely his covid infection verses his Moderna vaccination He was treated with plasmapheresis.  Client received dexamethasone, remdesivir, and zosyn and doxycycline when progressive leukocytosis and procalcitonin elevation was noted. Candida was cultured from tracheal aspirates but felt most likely d/t colonization with an option to treat further if he did not continue to improve. He is now extubated, unable to swallow and has profound weakness and distal sensory loss. He will transition to Acute rehab in the near future.  Comorbidities:as described in the above section and... DM2, CKD3, HTN, DJD, BPH ( h/o prostate surgery), h/o Lumbar surgery and hernia repair, GERD, hypothyroidism, hyperlipidemia.  Possible etiologies of his AIDP ( GBS)  would include his recent covid infection, the Moderna Vaccine, or other undiagnosed infection. He got his flu shot 9/25 ( fluzone sanofi) so this is not likely to be the culprit
On around 10/12/2022, I began having a runny nose. I don't think I have ever had a runny nose that bad in my life. A few days later, I developed a minor cough. Sunday, my cough had progressed, and I was coughing up a large amount of thick, yellow, mucus. The following Monday, I called my doctor who prescribed Prednisone and Ciprofloxacin. Today, I am not coughing up the mucus anymore and I am breathing much better again.
This spontaneous report was received from a healthcare worker refers to a patient of unknown age and gender (Patient record # 2878212). On 03-OCT-2014 the patient was vaccinated with improperly stored VAQTA 50 U (lot # J005010 and expiration date 23-OCT-2015 (reported also as 23-OCT-2014)) (dose and route of administration were not reported). No adverse effects were reported. This is one of several reports from the same reporter. Additional information has been requested.
COVID-19; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (COVID-19) in a 44-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Hashimoto's disease, Epstein-Barr virus infection, ADHD and Drug allergy. Concomitant products included LEVOTHYROXINE SODIUM (SYNTHROID), LIOTHYRONINE and LISDEXAMFETAMINE MESILATE (VYVANSE) for an unknown indication.   On 29-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 26-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 26-Oct-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced COVID-19 (COVID-19). The patient was treated with NIRMATRELVIR, RITONAVIR (PAXLOVID) from 16-May-2022 to 21-May-2022 for COVID-19 treatment, at an unspecified dose and frequency. At the time of the report, COVID-19 (COVID-19) outcome was unknown.            Further concomitant medication includes Vitamin supplement.  It was reported that the patient taken other medications/products within 2 weeks of starting COVID-19 treatment. Patient has previously received a COVID-19 Vaccine.  It was reported that unintended positive therapeutic benefit-Epstein Barr virus fatigue, energy and brain fog improvement experienced by patient after taking Paxlovid on 26-May-2022.  Device Date : 06Jun2022  Company comment: This spontaneous case concerns a 44-year-old female patient with no relevant medical history who experienced the unexpected non serious AESI of COVID 19 which occurred unknown days after the administration of third dose of mRNA-1273 vaccine in COVID 19 vaccination series. Patient received NIRMATRELVIR, RITONAVIR (Paxlovid) for the treatment of COVID-19 from 16-May to 22-May. The benefit-risk relationship of mRNA-1273 is not affected by this report.; Sender's Comments: This spontaneous case concerns a 44-year-old female patient with no relevant medical history who experienced the unexpected non serious AESI of COVID 19 which occurred unknown days after the administration of third dose of mRNA-1273 vaccine in COVID 19 vaccination series. Patient received NIRMATRELVIR, RITONAVIR (Paxlovid) for the treatment of COVID-19 from 16-May to 22-May. The benefit-risk relationship of mRNA-1273 is not affected by this report.
Sore from arm to chest, tingling/sensitive skin, chills, swollen /painful arm pit on arm were vaccine was received.
Body aches, fever, arrhythmias, chills, heat, redness, and  swelling at injection site, flu-like symptoms.
runny nose; was not feeling well; This spontaneous case was reported by a consumer and describes the occurrence of RHINORRHOEA (runny nose) and MALAISE (was not feeling well) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 02-Jun-2021, the patient experienced MALAISE (was not feeling well). On an unknown date, the patient experienced RHINORRHOEA (runny nose). At the time of the report, RHINORRHOEA (runny nose) and MALAISE (was not feeling well) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No Concomitant medications were provided  No Treatment medications were provided   Reporter did not allow further contact
Paralysis at injection site occurring approx 10 days after injection.  Still have this problem to date, 9 months later. Restricts lifting of arm slightly.    Feeling of a plugged ear started at the same time and still exists today as well.
Mom reports approx 5.5 hrs post vax pt face was swollen & puffy, esp around the eyes & lips; Seen by MD who reported there was also wheezing noted in lungs; Swelling lasted approx 24 hrs; rx DPH;
Pt recv vax on 10/18/96; on 3/17/99 pt exp varicella
DIZZINESS; FATIGUE/TIREDNESS; This spontaneous report received from a patient concerned a 73 year old male. The patient's height, and weight were not reported. The patient's concurrent conditions included hypothyroidism, sulfa allergy, azithromycin allergy, and non-smoker. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1808978, and expiry: UNKNOWN) dose was not reported, administered on 02-APR-2021 for prophylactic vaccination. Concomitant medications included levothyroxine sodium for hypothyroidism.  On 03-APR-2021, the subject experienced fatigue/tiredness. On 17-APR-2021, the subject experienced dizziness. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from dizziness on 18-APR-2021, and fatigue/tiredness on 04-APR-2021. This report was non-serious.
I began to itch 3 days after my vaccination shot. At first, I thought it was my eczema acting up, but then I began to itch and scratch all over my arms, underarms, legs, and on my hip bones. Hives have appeared on these areas. i applied flucinonide on the itchy areas, but they still remain itchy. I will see the doctor tomorrow, but I do not believe I can see the doctor who recommended the vaccination.
Swelling, redness, tenderness, pain and some pruritus 5 in x 5 3/4 in.
shingles; This case was reported by a consumer and described the occurrence of shingles in a 73-year-old male patient who received Herpes zoster (Shingles vaccine) (batch number 4S37J, expiry date unknown) for prophylaxis.   On 13th January 2023, the patient received Shingles vaccine .5 ml. On 14th January 2023, 1 days after receiving Shingles vaccine, the patient experienced shingles. On an unknown date, the outcome of the shingles was not recovered/not resolved.   It was unknown if the reporter considered the shingles to be related to Shingles vaccine.     Additional Information: GSK Receipt date: 20-Jan-2023. Reporter's Comments: The symptoms were treated. The reporter requesting consent to follow-up.
Initial report received on 24 April 2008 from a health care professional in the USA. A 51 year old male patient received on 21 April 2008 a left deltoid intramuscular injection of ADACEL (lot# C2937AA) and a left arm subcutaneous injection of IPOL (lot # A0490). On the evening of vaccination, the patient developed muscle pain, described as "feeling bruised", to the right lower extremity behind the thigh and also weakness in the leg. The patient self-medicated with an unspecified muscle relaxant, which seemed to help somewhat. The patient had no illness at the time of vaccination and had a history of coronary artery disease (CAD), rosacea, and allergies. Concomitant medications were unknown. At the time of the report, 24 April 2008, the patient had not recovered.
Swollen dry itchy lips; Swollen dry itchy lips; itchy lips; Redness around her lips; This spontaneous case was reported by a consumer and describes the occurrence of LIP SWELLING (Swollen dry itchy lips), LIP DRY (Swollen dry itchy lips), LIP PRURITUS (itchy lips) and LIP ERYTHEMA (Redness around her lips) in a 27-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 016B21A and 028A21A) for COVID-19 vaccination.     No Medical History information was reported.   On 25-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 22-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced LIP SWELLING (Swollen dry itchy lips), LIP DRY (Swollen dry itchy lips), LIP PRURITUS (itchy lips) and LIP ERYTHEMA (Redness around her lips). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL A) at a dose of 1 dosage form. At the time of the report, LIP SWELLING (Swollen dry itchy lips), LIP DRY (Swollen dry itchy lips), LIP PRURITUS (itchy lips) and LIP ERYTHEMA (Redness around her lips) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No any concomitant medications were reported. Patient took Oral steroid as treatment medication.   This case was linked to MOD-2021-421633 (Patient Link).
the vaccine that was administered on 10/17 had expired on 09/30/22. when reached out to the manufacturer they had reported that their vaccines stay effective for 30 days after administration date. This patient will need to re-vaccinate according to CDC guidance
Narrative: COVID infection following COVID vaccine series 02/17, Pfizer, dose #1 03/10 Pfizer, dose #2 08/07 pt cc: cough, loss of taste or smell, myalgias, rhinorrhea, fatigue, dyspnea exposure: unknown 08/12 COVID swab, result: detected 08/25 COVID swab, result: NOT detected
This spontaneous report was received from a nurse refers to a 50 year old patient's. On an unknown date in 2010 (also reported as four or five years ago) two or three patients who may have been under the age of 50 years old may have been vaccinated with ZOSTAVAX (dose, route and frequency were not reported). No adverse effects were reported. No further information was provided. Additional information has been requested.
Information has been received from a medical assistant concerning an adult male who was vaccinated with a dose of MMR II as a child. The patient had titers drawn and showed no immunity to mumps. The patient sought medical attention with an office visit. Additional information has been requested.
Mom describes red, hot and inflammed area about 6" in diameter on left thigh. First seen about 10:00 on 2/9/02. Mom had given Children's Motrin the night before. As of today, the area is flat and appears purplish and mottled but flat and not warm.
took the flu the next week and it hit me hard; Initial information received on 28-Nov-2022 regarding an unsolicited valid Social Media non-serious case received from a consumer/non-health-care professional.  This case involves an unknown age and unknown gender patient and took the flu the next week and it hit me hard after receiving influenza vaccine.  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.  On an unknown date, the patient received a dose of suspect influenza vaccine produced by unknown manufacturer (form, strength, dose, frequency, lot number, expiry date: unknown) via unknown route in unknown administration site for Prophylactic vaccination.  On an unknown date the patient had non serious event  took the flu the next week and it hit me hard (influenza) (unknown latency) following the administration of influenza vaccine.  Action taken was not applicable.  It was not reported if the patient received a corrective treatment for the event (took the flu the next week and it hit me hard ).  At time of reporting, the outcome was Unknown for the event.
Within 24 hours I was having left side chest pain/ache, then fever, chills, body aches, headache, stuffy nose.
Pt received 3rd dose of Hep A vaccine on 11/10/2021 at 0913.  Pt advise to wait outside of the waiting room to be monitored for adverse effects.  No symptoms reported by pt.  Offered to be consoled.
Significant edema, erythema (extending 13cm circumferentially), increased warmth, and pruritus to injection site.
Patient presented to clinic the day after vaccination with pain in his  left shoulder. The injection site was still visible and appeared to be above the recommended site for Deltoid injections. Patient reports decreased range of motion and pain.  It has been 3 weeks since injection and patient is still reporting pain and decreased range of motion. Provider has started a prescription of Prednisone 40 mg for 5 days.
11 a.m. the next morning starting feeling funny. by 4:30 headache, chills, body warm to touch, hands and feet ice cold. left eye cloudy/blurry and kept closing. Lasted until about 10:30 the next morning.
pt states the next day after he got the covid vax that he wasnt feeling well, he didnt feel right, foggy headed, felt  disoriented and confused.  He couldnt put words together to make a sentence.  He got up to go into the kitchen and then urinated all over himself.  He was worried about falling sleep, scared he would die in his sleep.  The 3rd woke up and was feeling some better but still foggy headed.  Pt went to the ER about 5 days later.  They did a CT and blood work.  He thinks the tests results came back negative. They wanted him to stay longer and maybe see a Neurologist but since there wasnt one available to see at that time the pt decided to go home.  He has blood work and urine labs to be done at the facility on 2/23/2021.  Pt states he is feeling better at this time.